Cold saline and endovascular cooling induces rapid hypothermia before reperfusion in STEMI patients treated with primary PCI, is safe and reduces infarct.

Slides:



Advertisements
Similar presentations
STEM-AMI OUTCOME TRIAL STem cElls Mobilization in Acute Myocardial Infarction Outcome Trial   A national, multicentre, randomised, open-label, Phase.
Advertisements

Endovascular treatment for Small Core and Anterior circulation Proximal occlusion with Emphasis on minimizing CT to recanalization times Michael D. Hill.
Dysfunctional but viable myocardium Ischemic heart disease assessed by MRI and SPECT Martin Ugander, MD Department of Clinical Sciences, Lund Department.
prognosis of patients with Acute Myocardial Infarction remains dismal.
Radial versus Femoral Randomized Investigation in ST Elevation Acute Coronary Syndrome the RIFLE STEACS study Enrico Romagnoli, MD PhD Principal investigators:
Trial profile Fox K et al. Lancet 2008;372:
Cyclosporine A reduces infarct size and has no detrimental effect of LV remodeling in STEMI patients Michel Ovize Cardiology Hospital and Inserm U886 Lyon.
Can we prevent stent restenosis after coronary stent implantation
Relationship of Time to Treatment and Door-to-Balloon Time to Mortality in Patients with Acute Myocardial Infarction Treated with Primary Angioplasty Christopher.
on behalf of the TOTAL Investigators
Glucose – Insulin – Potassium Study in Patients with ST Elevation Myocardial Infarction without Signs of Heart Failure Presented at American College of.
Post-Event Hypothermia Julie Swain M.D. Cardiovascular Surgeon Consultant to the FDA Circ System Devices Advisory Panel Sept 2004 DRAFT slides.
Clinical Trial Results. org Rescue Angioplasty or Repeat Fibrinolysis After Failed Fibrinolytic Therapy for ST-Segment Myocardial Infarction: A Meta-Analysis.
Clinical Trial Results. org Pexelizumab for Acute ST-Elevation Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary Intervention.
University Medical Center Groningen Thrombus aspiration during primary PCI FZ Thrombus Aspiration during Percutaneous coronary intervention in Acute.
The AiMI Trial Arshad Ali, MD, David Cox, MD, Nabil Dib, MD, Bruce Brodie, MD, Daniel Berman, MD, Navin Gupta, MD, Kevin Browne, MD, Robert Iwaoka, MD,
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
Welcome Ask The Experts March 24-27, 2007 New Orleans, LA.
SWEDE HEART Prospective Registry based Randomized Clinical Trials (RRCT) – a new concept for clinical research Lessons from the TASTE trial Stefan James,
” “The Dissociation Between Door-to- Balloon Time Improvement and Improvements in Other Acute Myocardial Infarction Care Processes and Patient Outcomes”
Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.
Hypothermia in awake STEMI patients:
TRI vs TFI in STEMI Shenyang Northern Hospital Wang Shouli Han Yalin.
Which Early ST-Elevation Myocardial Infarction Therapy (WEST) Trial Paul W. Armstrong, WEST Steering Committee Published in The European Heart Journal.
RESEARCH, REDUCE III, X-AMINE ST, COOL-MI Azfar Zaman Freeman Hospital, Newcastle.
A Prospective, Randomized Evaluation of Supersaturated Oxygen Therapy After Percutaneous Coronary Intervention in Acute Anterior Myocardial Infarction.
Late Open Artery Hypothesis Jason S. Finkelstein, M.D. Tulane University Medical Center 2/24/03.
Is there any role for intravascular ultrasound in bifurcation lesions? Giuseppe Biondi-Zoccai, MD University of Turin, Turin, Italy.
Issued in 2014 – SCAAR. SCAAR Annual report 2013.
Effect of Thrombus Aspiration in Patients With Myocardial Infarction Presenting Late After Symptom Onset Steffen Desch, MD Thomas Stiermaier, MD; Suzanne.
Date of download: 7/5/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early Aldosterone Blockade in Acute Myocardial Infarction:
Discontinuation of medication after nonfatal event: MI
iFR vs FFR-guided Coronary Intervention – iFR-SWEDEHEART
VELOCITY A Prospective, Randomized Trial of Peritoneal Hypothermia in Patients with Acute STEMI Undergoing PCI Gregg W. Stone, MD Columbia University Medical.
Figure 2 Kaplan–Meier estimates of event-free survival (survival to the combined endpoint). From: Long-term outcomes of patients with acute myocardial.
CRT 2011 Cool New Therapies for Cardiac Arrest: What you need to know to save lives Dr. Michael Mooney Director Interventional Cardiology Minneapolis Heart.
ASSENT-3 PLUS 1,639 patients with STEMI Treatment Group A
Is There a Role for Aspiration in STEMI?
Mortality Related to Periprocedural MI in CTO-PCI
Circ Cardiovasc Interv
Valsartan in Acute Myocardial Infarction Trial Investigators
The DANAMI-2 Trial Danish Trial in Acute Myocardial Infarction-2
Unadjusted 3-year cumulative incidence of adverse events after saphenous vein graft (SVG) percutaneous coronary intervention (PCI) with embolic protection.
Circ Cardiovasc Qual Outcomes
Circ Cardiovasc Interv
Circ Cardiovasc Interv
Figure 3 Ischaemic outcomes in the ST-segment elevation myocardial
European Society of Cardiology 2003
Nat. Rev. Cardiol. doi: /nrcardio
Figure 2 Ischaemic and bleeding outcomes in the major clinical trials
Figure 1 PCI strategies in patients with STEMI and multivessel disease
Nat. Rev. Cardiol. doi: /nrcardio
NIPPON Trial design: Patients undergoing percutaneous coronary intervention were randomized to short-term dual antiplatelet therapy (DAPT) (6 months; n.
American College of Cardiology Presented by Dr. Michel R. Le May
Figure 4 Observational studies on multiple treatment strategies
Global Registry of Acute Coronary Events: GRACE
Volume 383, Issue 9925, Pages (April 2014)
Flow chart of the Jakarta Cardiovascular Care Unit (CCU) Network System. Flow chart of the Jakarta Cardiovascular Care Unit (CCU) Network System. There.
(A) Meta-analysis of repeat revascularisation in randomised trials.
European Heart Journal Advance Access
Adjunctive Therapies in the Treatment of Acute Coronary Syndromes
Markov model scheme. Markov model scheme. Patients start (state 0) with uncomplicated PCI revascularisation; then cycle between health states until death.
Sirolimus Stent vs. Bare Stent in Acute Myocardial Infarction Trial
Cox regression of proportion mortality in the first 8 years for patients with three-vessel disease with a significant difference between the treatment.
Hypothermia in awake STEMI patients:
MRRs and EMRRs for women with ACS
A model of variation and accelerating factors in the process of acute care chain of patients with STEMI going for primary PCI. PCI, percutaneous coronary.
CIRCUS Trial design: Patients with anterior STEMI were randomized to IV cyclosporine 2.5 mg/kg (n = 475) vs. placebo (n = 495) immediately before coronary.
P2Y12 receptor inhibitor therapy for secondary prevention of patients with stable coronary artery disease. P2Y12 receptor inhibitor therapy for secondary.
FFR guided deferral of PCI in patients with ACS and stable coronary artery disease (SCAD). FFR guided deferral of PCI in patients with ACS and stable coronary.
Presentation transcript:

Cold saline and endovascular cooling induces rapid hypothermia before reperfusion in STEMI patients treated with primary PCI, is safe and reduces infarct size with a scattered myocardial salvage Presented by Prof David Erlinge, MD, PhD, On behalf of the RAPID MI-ICE Investigators Matthias Götberg, MD, Göran Olivecrona, MD,PhD, Sasha Koul, MD, Marcus Carlsson, MD, PhD, Henrik Engblom, MD, PhD, Martin Ugander, MD, PhD, Jesper van der Pals, MD, Lars Algotsson, MD, PhD Håkan Arheden, MD, PhD, David Erlinge, MD, PhD Lund University, Skane University Hospital Lund, Sweden Disclosure statement: The study was partly sponsored by an unrestricted research grant from Innercool Therapies, a fully owned subsidiary of Philips Healthcare.

In a pig model, we have shown that myocardial infarct size is significantly reduced only if the temperature < 35°C before reperfusion 3. 1 Duncker et al (Am J Physiol 270, H1189), 2 Dae MW, et al (Am J Physiol Heart Circ Physiol 282:H )., 3 Götberg M et al. BMC Cardiovasc Disord. 2008, 8:7, 4 Grines CL et al. TCT 2004, 5 O'Neill WW et al. TCT 2004 Two large randomized trials using hypothermia as adjunct treatment to primary PCI in patients with acute MI (ICE-IT 4 and COOL MI 5 ), failed to reach primary endpoint. However, only 1/3 of the patients randomized to hypothermia reached a core body temperature < 35°C at the time of reperfusion. The subgroups of patients randomized to hypothermia and who reached < 35°C at the time of reperfusion seemed to benefit (RRR 49% and 43% respectively) Hypothermia in Acute MI A large number of animal studies have shown that hypothermia reduces myocardial infarct size 1-2.

Hypothermia in Acute MI We hypotesized that a combination of cold saline and endovascular cooling would cool all patients to target temp < 35°C before primary PCI reperfusion.

RAPID MI-ICE The Rapid Intravascular Cooling in Myocardial Infarction as Adjunctive to Percutaneous Coronary Intervention study (Safety & Feasibility study in man) 20 Patients Anterior or large Inferior STEMI <6 hrs from onset of symtoms Rapid infusion 1-2 liters 4°C Saline solution. Endovascular cooling with Philips InnerCool endovascular system with Accutrol catheter starting before angiogram and continuing 3 h after PCI Cardiac MRI day 4±2, infarct size/ myocardium at risk (T2 stir)  Primary outcome:Safety and Feasibility  Secondary outcome: Reduction in infarct size

Timeline STEMI Ambulance Reperfusion Arrival Cathlab 30 min → several h 15 min Angio- graphy 15 min PCI Buspirone Meperidine iv Cold saline 1-2 l Endovascular catheter placement Temp

Feasibility Arrival at cath lab ECG Patient Info Randomization Time of reperfusion Initiation of cold saline infusion Initiation of endovascular cooling Patient prep, catheterization Angiography, PCI End of PCI 14 ± 5 min14 ± 6 min15 ± 3 min 40 ± 6 min Hypothermia Control 3 min prolonged procedure before reperfusion Temp: 34.7 ± 0.3°C at reperfusion All patients reached target temp

Clinical and Angiographic Data VariableHypothermia (n=9)Control (n=9) Age62 ± 1058 ± 7NS Women2 2 NS Hypertension3 2 NS Diabetes1 2 NS Infarct related artery LAD6 7NS RCA3 2 NS Initial TIMI flow 0/17 8 NS 2/32 1 NS Onset of symptoms 174 ± ± 62NS to reperfusion (min) Door-to-balloon time (min)43 ± 740 ± 6NS Successful revascularization9 9NS TIMI 3 flow post PCI99NS Thrombectomy8 7 NS Abciximab6 6 NS Bivalirudin3 3 NS 2/20 patients, One from each group was excluded for technical reasons

VariableHypothermia Control (n=9) 30 day mortality0 0 Re-infarction0 0 CABG day MACE0 0 Heart failure0 3 VT/VF0 2 Stroke0 0 Infection3 0 Major bleeding0 0 Bradycardia0 0 Safety NT-proBNP day 1 HypothermiaControl NT-proBNP (ng/l)

Reduction of infarct size Final Infarct Size/ Myocardium at Risk Reduction in Troponin (Peak value) Efficacy p = 0·04 HypothermiaControl Δ = 38% Infarct size / Myocardium at risk HypothermiaControl Troponin T (ug/l) p = 0·01 Δ = 43%

Speckled infarction in pig Wavefront phenomenon (Jennings) Hypothermia Normothermia Hypothermia causes disruption of the wavefront phenomenon. Götberg M et al. BMC Cardiovasc Disord. 2008, 8:7 Also seen in hypothermia treatment by Dae et al., Am J Physiol, 2002, with SPECT

Speckled infarction in man

Troponin T release was significantly reduced. Rapid induction of hypothermia with 1-2 l cold saline and endovascular catheter is safe and feasible in awake patients with acute MI. Conclusions Myocardial infarct size was significantly reduced. A Randomized multicenter trial with hypothermia to reduce infarct size is planned (CHILL-MI). All patients reached target temperature, <35°C, at the time of reperfusion. Hypothermia disrupts the wavefront phenomenon into a speckled infarction. The study is accepted for publication in Circulation: Cardiovascular Interventions